BioSpace News Archive

Business

Zymeworks Appoints New Director - June 29, 2023

Zymeworks Inc., a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, announced the appointment of Mr. Carlos E. Campoy to its board of directors effective as of June 30, 2023.

June 29, 2023
·
7 min read
Pharm Country

PTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone for the Treatment of Mitochondrial Disease Associated Seizures

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the MIT-E trial of vatiquinone for the treatment of mitochondrial disease associated seizures (MDAS) failed to achieve its primary endpoint of reduction in observable motor seizures.

June 29, 2023
·
5 min read
Policy

AVITA Medical Submits FDA PMA Supplement for RECELL GO

AVITA Medical, Inc. announced its submission of a premarket approval supplement to the U.S. Food and Drug Administration for RECELL GO™.

June 29, 2023
·
4 min read
Drug Development

Corvus Pharmaceuticals Presents New Ciforadenant Preclinical Data at the 2nd JCA-AACR Precision Cancer Medicine International Conference

Corvus Pharmaceuticals, Inc. today announced new preclinical data for ciforadenant, the Company’s adenosine 2A receptor inhibitor, highlighting its mechanism of action and synergy with immune checkpoint inhibitors via combination with anti-CTLA-4 and anti-PD-1 therapies.

June 29, 2023
·
6 min read
Business

Numinus to Host Q3 2023 Results Conference Call on July 17, 2023

Numinus Wellness Inc. will release its financial results for the quarter ended May 31, 2023, after market close on Monday, July 17, 2023.

June 29, 2023
·
2 min read
Business

Ambrosia Bio Leverages Ginkgo Enzyme Services to Develop a More Scalable Enzymatic Process for Allulose

Ambrosia Bio today announced that Ambrosia Bio will leverage Ginkgo Enzyme Services, including its proprietary chassis organisms, to develop an expression strain for the scalable production of the Ambrosia Bio proprietary enzymes used for the conversion of feedstock into allulose.

June 29, 2023
·
7 min read
Business

Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023

Rallybio Corporation today announced that Stephen Uden, M.D., Rallybio’s President, Chief Operating Officer and Co-Founder has been appointed to the role of Chief Executive Officer, effective August 1, 2023.

June 29, 2023
·
8 min read
Can-Fite Receives U.S. FDA’s Go Ahead for Piclidenoson Psoriasis Registration Plan

Can-Fite BioPharma Ltd today announced that it received feedback and advice from the U.S. Food and Drug Administration (FDA) with respect to non-clinical and clinical development and registration plans for Piclidenoson for the treatment of patients with moderate to severe plaque psoriasis.

June 29, 2023
·
6 min read
Solar Powered Sunscreen: EcoZinc a World First in Sustainable Zinc Oxide Innovation

Advance ZincTek , Australia’s leading manufacturer of natural Sunscreen Actives, announces the launch of EcoZinc , the world’s first solar-powered, non-nano zinc oxide powder for SPF-rated cosmetics and sunscreens.

June 29, 2023
·
2 min read
Business

NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors

NeoGenomics, Inc. today announced the appointment of Elizabeth Floegel, Neil Gunn, and Tony Zook to its Board of Directors.

June 29, 2023
·
5 min read